Related references
Note: Only part of the references are listed.p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Alina Molchadsky et al.
CARCINOGENESIS (2010)
Biologic Modulation of Chemotherapy in Patients With Hepatic Colorectal Metastases: The Role of Anti-VEGF and Anti-EGFR Antibodies
Ravit Geva et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Apoptosis screening of human chromosome 21 proteins reveals novel cell death regulators
Yuhui Hu et al.
MOLECULAR BIOLOGY REPORTS (2010)
Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells
Lili Wang et al.
MOLECULAR BIOLOGY REPORTS (2010)
Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction
Junming Tang et al.
MOLECULES AND CELLS (2010)
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V. Ramakrishnan et al.
ONCOGENE (2010)
Cell adhesion molecules regulate contractile ring-independent cytokinesis in Dictyostelium discoideum
Akira Nagasaki et al.
CELL RESEARCH (2009)
Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway
Junming Tang et al.
EXPERIMENTAL CELL RESEARCH (2009)
Differential regulation of p53 function by protein kinase C isoforms revealed by a yeast cell system
Isabel Coutinho et al.
FEBS LETTERS (2009)
Role of RAF/MEK/ERK Pathway, p-STAT-3 and Mcl-1 in Sorafenib Activity in Human Pancreatic Cancer Cell Lines
Paola Ulivi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
p53 family in development
Nadia Danilova et al.
MECHANISMS OF DEVELOPMENT (2008)
Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction
Yuan-Yuan Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma
Trang-Tiau Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies
Klaus Podar et al.
CELL CYCLE (2007)
Autocrine VEGF loops, signaling pathways, and acute leukemia regulation
Rita Fragoso et al.
LEUKEMIA & LYMPHOMA (2007)
Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues
Geertu Deli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways
SCR Santos et al.
BLOOD (2004)
A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C α and θ isoforms
L Deeds et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
NH Fernando et al.
SEMINARS IN ONCOLOGY (2003)
Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications
N Ferrara
SEMINARS IN ONCOLOGY (2002)
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
HP Gerber et al.
NATURE (2002)
Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
S Dias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
S Dias et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
